Talk:Zava
(Redirected from Draft talk:Zava)
Latest comment: 5 years ago by Bbarmadillo in topic A Further Comment
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||||||||||||||||
|
The Wikimedia Foundation's Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see WP:PAID. For advice about reviewing paid contributions, see WP:COIRESPONSE.
|
Some comments
editThe article is in good shape! Here are some minor things that caught my eye:
- Does Zava's parent company Health Bridge Ltd have any connection to HealthBridge?
- No relation.
- The beginning of the History section is a little confusing. How can the company have been "established" in 2010 but "launched" in 2011? I suspect that the website was simply "launched" in 2011.
- Done
- I recommend some specific examples of opposition from pharmacists in Switzerland. Why did they criticize the company?
- I thought about making a part about Swiss controversies, but it was very hard to read in German. The same reason as in all the other EU countries (local/global) law conflict.
- In the second paragraph of the 'History section, "urgent" prescriptions should probably be changed to "emergency".
- Done
- If it matters, add a reason for the name change from DrEd to Zava.
- I couldn't find a reason for this, but my guess is that after "Dr. Ed ban" in Germany, the company simply didn't want to be associated with it. But I will look further.
- At the end of the Regulation section, add some specific text on how and why several EU countries questioned "the legal grounds", or at least alert the reader that some examples are available later in the article.
- Possibly, will just include a mention of "Controversies" there.
---DOOMSDAYER520 (Talk|Contribs) 18:20, 14 July 2019 (UTC)
Thanks a lot! Very helful! --Bbarmadillo (talk) 21:10, 14 July 2019 (UTC)
- @Doomsdayer520: Thanks again for the review. I've made several changes to the article following your comments. Can I also ask you to add an editor comment to the draft? It should make the reviewer's job easier. --Bbarmadillo (talk) 17:59, 22 July 2019 (UTC)
- Okay, but I'm not sure where/how/when that is done. Point me in the right direction. ---DOOMSDAYER520 (Talk|Contribs) 18:02, 22 July 2019 (UTC)
- @Doomsdayer520: It should be at the "Review" tab. This manual says "click the Comment option from the Review tab". Or you can just use this template. --Bbarmadillo (talk) 18:24, 22 July 2019 (UTC)
- I do not have a "Review" tab, and does one need to be an actual AfC Reviewer to see this tab? In any case, I am actually a New Pages Reviewer. You can send anyone from the AfC team to this thread or to me directly if more info is needed. I have one more precise comment that I will make below, just for the record. ---DOOMSDAYER520 (Talk|Contribs) 18:59, 22 July 2019 (UTC)
- Okay, but I'm not sure where/how/when that is done. Point me in the right direction. ---DOOMSDAYER520 (Talk|Contribs) 18:02, 22 July 2019 (UTC)
- @Doomsdayer520: Thanks again for the review. I've made several changes to the article following your comments. Can I also ask you to add an editor comment to the draft? It should make the reviewer's job easier. --Bbarmadillo (talk) 17:59, 22 July 2019 (UTC)
A Further Comment
editTo the AfC Team and other reviewers, please see the thread above for some recommendations I made for the article, and the author's successful efforts to address them. I would also like to point out that while the author has a paid connection to the company, the article does not sugarcoat the criticism and bad news received by the company and does not try to steer the reader toward any sort of conclusion. That reflects a solid effort to avoid bias. ---DOOMSDAYER520 (Talk|Contribs) 19:02, 22 July 2019 (UTC)
- @Doomsdayer520: Thank you, very kind of you! --Bbarmadillo (talk) 19:59, 22 July 2019 (UTC)